Submitted by Anonymous (not verified) on 20 August 2025 - 12:37
Human medicines European public assessment report (EPAR): Abrysvo, respiratory syncytial virus vaccine (bivalent, recombinant), Date of authorisation: 23/08/2023, Revision: 11, Status: Authorised
Source: